Adverse events480

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 480

Type	Event	Organ system	Group	Affected	At risk
other	Lymphadenopathy	Blood and lymphatic system disorders	Core Study Part I: Canakinumab	0	20
other	Lymphadenopathy	Blood and lymphatic system disorders	Core Study Part I: Placebo	0	15
other	Lymphadenopathy	Blood and lymphatic system disorders	Core Study Part II: Canakinumab Responders	0	14
other	Lymphadenopathy	Blood and lymphatic system disorders	Core Study Part II: Placebo Responders	0	2
other	Lymphadenopathy	Blood and lymphatic system disorders	Core Study Part II: Placebo Non-responders	1	7
other	Lymphadenopathy	Blood and lymphatic system disorders	LTE Phase: Canakinumab	0	7
other	Eyelid oedema	Eye disorders	Core Study Part I: Canakinumab	2	20
other	Eyelid oedema	Eye disorders	Core Study Part I: Placebo	0	15
other	Eyelid oedema	Eye disorders	Core Study Part II: Canakinumab Responders	0	14
other	Eyelid oedema	Eye disorders	Core Study Part II: Placebo Responders	0	2
other	Eyelid oedema	Eye disorders	Core Study Part II: Placebo Non-responders	0	7
other	Eyelid oedema	Eye disorders	LTE Phase: Canakinumab	0	7
other	Visual impairment	Eye disorders	Core Study Part I: Canakinumab	1	20
other	Visual impairment	Eye disorders	Core Study Part I: Placebo	2	15
other	Visual impairment	Eye disorders	Core Study Part II: Canakinumab Responders	0	14
other	Visual impairment	Eye disorders	Core Study Part II: Placebo Responders	0	2
other	Visual impairment	Eye disorders	Core Study Part II: Placebo Non-responders	0	7
other	Visual impairment	Eye disorders	LTE Phase: Canakinumab	0	7
other	Abdominal pain	Gastrointestinal disorders	Core Study Part I: Canakinumab	1	20
other	Abdominal pain	Gastrointestinal disorders	Core Study Part I: Placebo	0	15

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02204293/events

API reference For AI assistants

Adverse events480

Sources 3

Read this list from software.